Sigma Planning Corp Has $1.94 Million Holdings in SPDR S&P Biotech ETF $XBI

Sigma Planning Corp lessened its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,203 shares of the exchange traded fund’s stock after selling 5,285 shares during the period. Sigma Planning Corp’s holdings in SPDR S&P Biotech ETF were worth $1,942,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of XBI. Avoro Capital Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $256,053,000. Wells Fargo & Company MN increased its holdings in SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after purchasing an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp raised its position in SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares during the last quarter. Morgan Stanley raised its position in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 1,042,265.6% during the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after purchasing an additional 635,782 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI opened at $152.00 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $84.39 and a fifty-two week high of $165.71. The company’s 50 day moving average price is $142.06 and its two-hundred day moving average price is $132.23. The firm has a market capitalization of $10.34 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.